Jane Street
TAK icon

Jane Street’s Takeda Pharmaceutical TAK Stock Holding History

Jane Street’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,617,800
Closed -$24.1M – 10852
2025
Q1 		$24.1M Buy
+1,617,800
New +$22.7M 0.01% 1162
2024
Q3 		– Sell
-858,500
Closed -$11.1M – 10384
2024
Q2 		$11.1M Buy
858,500
+847,000
+7,365% +$11.2M ﹤0.01% 1926
2024
Q1 		$159K Sell
11,500
-14,400
-56% -$209K ﹤0.01% 8316
2023
Q4 		$372K Sell
25,900
-905,900
-97% -$12.9M ﹤0.01% 7284
2023
Q3 		$14.5M Buy
931,800
+28,700
+3% +$444K ﹤0.01% 1389
2023
Q2 		$14.2M Sell
903,100
-97,100
-10% -$1.59M ﹤0.01% 1544
2023
Q1 		$16.4M Buy
1,000,200
+80,900
+9% +$1.29M 0.01% 1161
2022
Q4 		$14.4M Buy
919,300
+831,400
+946% +$11.6M 0.01% 1273
2022
Q3 		$1.14M Sell
87,900
-805,300
-90% -$11.2M ﹤0.01% 5170
2022
Q2 		$12.6M Buy
893,200
+706,600
+379% +$10.1M 0.01% 1507
2022
Q1 		$2.68M Sell
186,600
-797,000
-81% -$11.7M ﹤0.01% 4188
2021
Q4 		$13.4M Sell
983,600
-91,400
-9% -$1.28M ﹤0.01% 1551
2021
Q3 		$17.9M Buy
1,075,000
+981,300
+1,047% +$16.5M 0.01% 1215
2021
Q2 		$1.57M Sell
93,700
-96,400
-51% -$1.64M ﹤0.01% 4835
2021
Q1 		$3.42M Buy
190,100
+71,000
+60% +$1.28M ﹤0.01% 3005
2020
Q4 		$2.17M Buy
119,100
+63,500
+114% +$1.11M ﹤0.01% 3346
2020
Q3 		$987K Sell
55,600
-16,100
-22% -$293K ﹤0.01% 4118
2020
Q2 		$1.28M Buy
+71,700
New +$1.29M ﹤0.01% 3719

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's TAK Position: Q4 2025 in Review

Jane Street sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 106,290 shares — an estimated $1.56M sold.

Jane Street first reported a position in TAK in Q4 2018 and held it in 26 quarters. The position peaked at $16.3M in Q4 2023. 348 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • Jane Street reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 106,290 Takeda Pharmaceutical shares in Q4 2025, an estimated $1.56M.
  • Jane Street first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 26 quarters.
  • Jane Street's Takeda Pharmaceutical position peaked at $16.3M in Q4 2023.
  • 348 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.